Now showing items 1-2 of 2

    • Clinical Insights Into the Biology and Treatment of Pancreatic Cancer. 

      Mettu, NB; Abbruzzese, JL (J Oncol Pract, 2016-01)
      Pancreatic cancer is a devastating disease with a universally poor prognosis. In 2015, it is estimated that there will be 48,960 new cases of pancreatic cancer and that 40,560 people will die of the disease. The 5-year ...
    • Development of a Novel c-MET-Based CTC Detection Platform. 

      Zhang, T; Boominathan, R; Foulk, B; Rao, C; Kemeny, G; Strickler, JH; Abbruzzese, JL; Harrison, MR; Hsu, DS; Healy, P; Li, J; Pi, C; Prendergast, KM; Hobbs, C; Gemberling, S; George, DJ; Hurwitz, HI; Connelly, M; Garcia-Blanco, MA; Armstrong, AJ (Mol Cancer Res, 2016-06)
      UNLABELLED: Amplification of the MET oncogene is associated with poor prognosis, metastatic dissemination, and drug resistance in many malignancies. We developed a method to capture and characterize circulating tumor cells ...